Not finding it? Sign in to also search OpenAlex live.
-
Long-term outcome and risk factors for relapse after allogeneic hematopoietic stem cell transplantation in myelofibrosis: Results from a large multicenter cohort2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Julia-Annabell Georgi, Sebastian Stasik, Michael Krämer, Tobias A.W. Holderried, Jochen J. Frietsch, Stefan Klein, +18 more
0citations -
Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia
Peter A. von dem Borne, Tjeerd J.F. Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriëtte Levenga, +9 more
1citations -
Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia: A Systematic Review and Meta-analysis2020 Schizophrenia Bulletin Open review Medicine Schizophrenia research and treatment Open access cited by 1 patent
Jan P.A.M. Bogers, George Hambarian, Maykel Michiels, Jentien M. Vermeulen, Lieuwe de Haan
33citations -
P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT
Romain Tilmont, Ibrahim Yakoub‐Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Nicolaas PM Schaap, +18 more
1citations -
P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION
Grzegorz Władysław Basak, Christophe Peczynski, Christian Koenecke, Sofie Rosanne Terwel, Y. Cabrerizo, Olaf Penack, +19 more
0citations -
T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS2020 Schizophrenia Bulletin conference-abstract Medicine Schizophrenia research and treatment Open access
Jan P.A.M. Bogers, George Hambarian, Jentien M. Vermeulen, Lieuwe de Haan
2citations -
A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party
Meral Beksaç, Simona Iacobelli, Linda Köster, Didier Blaise, Jan J. Cornelissen, Peter Pal Remenyi, +19 more
4citations -
High Relapse Rate in Anti-CASPR2 Disease2025 Neurology Neuroimmunology & Neuroinflammation article Medicine Autoimmune Neurological Disorders and Treatments Open access
Tessa Brand, Suzanne C. Franken, Marie R. Vermeiren, Agnes van Sonderen, Marienke A.A.M. de Bruijn, Yvette S. Crijnen, +8 more
7citations -
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT2023 Bone Marrow Transplantation article Medicine Multiple Myeloma Research and Treatments Open access
Rémi Tilmont, Ibrahim Yakoub‐Agha, Diderik-Jan Eikema, Nienke Zinger, Mathias Haenel, Nicolaas PM Schaap, +20 more
2citations -
Data from Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival
Caroline Conway, Angana Mitra, Rosalyn Jewell, Juliette A. Randerson‐Moor, Samira Lobo, Sara Edward, +8 more
0citations -
Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study
Lisa V. E. Oostenbrink, Erik G. J. von Asmuth, Cornelia M. Jol‐van der Zijde, Anja M. Jansen-Hoogendijk, Carly Vervat, Robbert G. M. Bredius, +9 more
4citations -
Long-term comparative outcomes in relapse activity and disability progression among anti-CD20 therapies in relapsing multiple sclerosis: An unanchored matching-adjusted indirect comparison2026 Multiple Sclerosis and Related Disorders article Medicine Multiple Sclerosis Research Studies Open access
Ralf Gold, Amir Ansaripour, Klaus Schmierer, Michael Barnett, Hans Peter Hartung, Yamout Bassem, +8 more
0citations -
Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
Peter A. von dem Borne, Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Daniëlle van Lammeren, +10 more
0citations -
Long-term Outcome of a DLI-based Treatment Strategy in Patients With Relapsed AML After TCD Allogeneic Stem Cell Transplantation is Hampered by GvHD and Late Relapse2026 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access
J.E. Bergsma, Eva M. Argiro, K A Oosterink, Peter van Balen, J.G.K. van der Hem, Daniëlle van Lammeren, +6 more
1citations